RhumbLine Advisers’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $838K | Buy |
91,864
+7,509
| +9% | +$68.5K | ﹤0.01% | 2340 |
|
|
2025
Q1 | $671K | Sell |
84,355
-2,968
| -3% | -$23.6K | ﹤0.01% | 2377 |
|
|
2024
Q4 | $474K | Buy |
87,323
+1,237
| +1% | +$6.72K | ﹤0.01% | 2712 |
|
|
2024
Q3 | $622K | Sell |
86,086
-4,916
| -5% | -$35.5K | ﹤0.01% | 2555 |
|
|
2024
Q2 | $988K | Buy |
91,002
+13,573
| +18% | +$147K | ﹤0.01% | 2256 |
|
|
2024
Q1 | $1.45M | Buy |
77,429
+1,746
| +2% | +$32.7K | ﹤0.01% | 2071 |
|
|
2023
Q4 | $1.64M | Sell |
75,683
-361
| -0.5% | -$7.82K | ﹤0.01% | 2007 |
|
|
2023
Q3 | $1.56M | Buy |
76,044
+784
| +1% | +$16.1K | ﹤0.01% | 1978 |
|
|
2023
Q2 | $3.54M | Sell |
75,260
-10,633
| -12% | -$500K | ﹤0.01% | 1588 |
|
|
2023
Q1 | $3.6M | Buy |
85,893
+1,859
| +2% | +$78K | ﹤0.01% | 1501 |
|
|
2022
Q4 | $3.21M | Buy |
84,034
+1,440
| +2% | +$54.9K | ﹤0.01% | 1549 |
|
|
2022
Q3 | $3.23M | Buy |
82,594
+5,405
| +7% | +$212K | ﹤0.01% | 1493 |
|
|
2022
Q2 | $2.49M | Buy |
77,189
+34,865
| +82% | +$1.13M | ﹤0.01% | 1652 |
|
|
2022
Q1 | $1.4M | Sell |
42,324
-5,524
| -12% | -$183K | ﹤0.01% | 1986 |
|
|
2021
Q4 | $2.04M | Buy |
47,848
+92
| +0.2% | +$3.91K | ﹤0.01% | 1874 |
|
|
2021
Q3 | $2.12M | Sell |
47,756
-4,285
| -8% | -$190K | ﹤0.01% | 1883 |
|
|
2021
Q2 | $2.96M | Sell |
52,041
-3,404
| -6% | -$193K | ﹤0.01% | 1742 |
|
|
2021
Q1 | $4.15M | Sell |
55,445
-2,130
| -4% | -$159K | 0.01% | 1512 |
|
|
2020
Q4 | $4.98M | Buy |
57,575
+1,010
| +2% | +$87.4K | 0.01% | 1358 |
|
|
2020
Q3 | $3.46M | Sell |
56,565
-1,010
| -2% | -$61.7K | 0.01% | 1384 |
|
|
2020
Q2 | $2.39M | Buy |
57,575
+6,351
| +12% | +$264K | ﹤0.01% | 1627 |
|
|
2020
Q1 | $1.47M | Sell |
51,224
-716
| -1% | -$20.6K | ﹤0.01% | 1709 |
|
|
2019
Q4 | $3.75M | Buy |
51,940
+1,172
| +2% | +$84.6K | 0.01% | 1436 |
|
|
2019
Q3 | $7.12M | Sell |
50,768
-244
| -0.5% | -$34.2K | 0.01% | 980 |
|
|
2019
Q2 | $9.34M | Buy |
51,012
+2,328
| +5% | +$426K | 0.02% | 808 |
|
|
2019
Q1 | $7.74M | Buy |
48,684
+1,777
| +4% | +$283K | 0.02% | 908 |
|
|
2018
Q4 | $4.49M | Sell |
46,907
-1,430
| -3% | -$137K | 0.01% | 1170 |
|
|
2018
Q3 | $6.83M | Sell |
48,337
-925
| -2% | -$131K | 0.01% | 908 |
|
|
2018
Q2 | $7.71M | Buy |
49,262
+8,307
| +20% | +$1.3M | 0.02% | 810 |
|
|
2018
Q1 | $6.6M | Buy |
40,955
+2,429
| +6% | +$391K | 0.01% | 872 |
|
|
2017
Q4 | $6.35M | Sell |
38,526
-3,845
| -9% | -$633K | 0.01% | 922 |
|
|
2017
Q3 | $2.64M | Buy |
42,371
+1,233
| +3% | +$76.8K | 0.01% | 1426 |
|
|
2017
Q2 | $3.28M | Buy |
41,138
+3,551
| +9% | +$283K | 0.01% | 1260 |
|
|
2017
Q1 | $2.67M | Buy |
37,587
+1,458
| +4% | +$104K | 0.01% | 1385 |
|
|
2016
Q4 | $1.85M | Buy |
36,129
+7,170
| +25% | +$366K | ﹤0.01% | 1494 |
|
|
2016
Q3 | $1.33M | Buy |
28,959
+4,622
| +19% | +$213K | ﹤0.01% | 1658 |
|
|
2016
Q2 | $733K | Buy |
24,337
+9,047
| +59% | +$272K | ﹤0.01% | 1973 |
|
|
2016
Q1 | $490K | Buy |
15,290
+1,755
| +13% | +$56.2K | ﹤0.01% | 2241 |
|
|
2015
Q4 | $789K | Buy |
13,535
+1,380
| +11% | +$80.4K | ﹤0.01% | 1957 |
|
|
2015
Q3 | $514K | Buy |
12,155
+545
| +5% | +$23K | ﹤0.01% | 2209 |
|
|
2015
Q2 | $848K | Buy |
+11,610
| New | +$848K | ﹤0.01% | 1974 |
|